|
|
Jeffrey A. Meyerhardt, MD, MPH
Publications
- Baba Y, Nosho K, Shima K, Hayashi M, Meyerhardt JA, Chan AT, Giovannucci E, Fuchs CS, Ogino S.Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers.Cancer. 2011 Apr 1;117(7):1399-408.
21425139 - Ng K, Sargent DJ, Goldberg RM, Meyerhardt JA, Green EM, Pitot HC, Hollis BW, Pollak MN, Fuchs CS.Vitamin D Status in Patients With Stage IV Colorectal Cancer: Findings From Intergroup Trial N9741.J Clin Oncol. 2011 Mar 21.
21422438 - Meyerhardt JA.Adjuvant Therapy for Stage II and III Colon Cancer.Clin Adv Hematol Oncol. 2010 Nov;8(11):772-4.
21326156 - Chan JA, Blaszkowsky LS, Enzinger PC, Ryan DP, Abrams TA, Zhu AX, Temel JS, Schrag D, Bhargava P, Meyerhardt JA, Wolpin BM, Fidias P, Zheng H, Florio S, Regan E, Fuchs CS.A multicenter phase II trial of single-agent cetuximab in advanced esophageal and ga
21217058 - Shima K, Nosho K, Baba Y, Cantor M, Meyerhardt JA, Giovannucci EL, Fuchs CS, Ogino S.Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.Int J Cancer. 2011 Mar 1
20473920 - Bao Y, Nimptsch K, Meyerhardt J, Chan AT, Ng K, Michaud DS, Brand-Miller JC, Willett WC, Giovannucci E, Fuchs CS.Dietary insulin load, dietary insulin index, and colorectal cancer.Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3020-6.
20924099 - Baba Y, Nosho K, Shima K, Hayashi M, Meyerhardt JA, Chan AT, Giovannucci E, Fuchs CS, Ogino S.Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers.Cancer. 2010 Nov 8.
21061337 - Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Meyerhardt JA, Giovannucci E, Dranoff G, Fuchs CS, Ogino S.Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.J Pathol. 2010 Dec;222(
20927778 - Kulke MH, Chan JA, Meyerhardt JA, Zhu AX, Abrams TA, Blaszkowsky LS, Regan E, Sidor C, Fuchs CS.A prospective phase II study of 2-methoxyestradiol administered in combination with bevacizumab in patients with metastatic carcinoid tumors.Cancer Chemother P
20960192 - Ng K, Meyerhardt JA, Chan JA, Niedzwiecki D, Hollis DR, Saltz LB, Mayer RJ, Benson AB, Schaefer PL, Whittom R, Hantel A, Goldberg RM, Fuchs CS.Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: f
20805450 - Baba Y, Nosho K, Shima K, Meyerhardt JA, Chan AT, Engelman JA, Cantley LC, Loda M, Giovannucci E, Fuchs CS, Ogino S.Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer.Br J Cancer. 2010 S
20808308 - Meyerhardt JA, Ma J, Courneya KS.Energetics in colorectal and prostate cancer.J Clin Oncol. 2010 Sep 10;28(26):4066-73. Review.
20644082 - Goodwin PJ, Meyerhardt JA, Hursting SD.Host factors and cancer outcome.J Clin Oncol. 2010 Sep 10;28(26):4019-21.
20697081 - Baba Y, Nosho K, Shima K, Irahara N, Chan AT, Meyerhardt JA, Chung DC, Giovannucci EL, Fuchs CS, Ogino S.HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.Am J Pathol. 2010 May;176(5):2292-301.
20363910 - McCleary NJ, Meyerhardt JA.New developments in the adjuvant therapy of stage II colon cancer. Risk assessments in the older patient.Oncology (Huntingt). 2010 Jan;24(1 Suppl 1):3-8.
20225605 - McCleary NJ, Niedzwiecki D, Hollis D, Saltz LB, Schaefer P, Whittom R, Hantel A, Benson A, Goldberg R, Meyerhardt JA.Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803.Cancer. 2010 Feb 15;116(4):957-6
20052723 - Ogino S, Nosho K, Irahara N, Shima K, Baba Y, Kirkner GJ, Mino-Kenudson M, Giovannucci EL, Meyerhardt JA, Fuchs CS.Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lympho
19809407 - Zhu AX, Meyerhardt JA, Blaszkowsky LS, Kambadakone AR, Muzikansky A, Zheng H, Clark JW, Abrams TA, Chan JA, Enzinger PC, Bhargava P, Kwak EL, Allen JN, Jain SR, Stuart K, Horgan K, Sheehan S, Fuchs CS, Ryan DP, Sahani DV.Efficacy and safety of gemcitabine
19932054 - Meyerhardt JA, Giovannucci EL, Ogino S, Kirkner GJ, Chan AT, Willett W, Fuchs CS.Physical activity and male colorectal cancer survival.Arch Intern Med. 2009 Dec 14;169(22):2102-8.
20008694 - Ogino S, Meyerhardt JA, Irahara N, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Schaefer P, Whittom R, Hantel A, Benson AB, Goldberg RM, Bertagnolli MM, Fuchs CS, , , , .KRAS mutation in stage III colon cancer and clinical outcome following intergroup
19934290 - Myers AP, Meyerhardt JA, Cantley LC.Getting knit-PI3Ky: PIK3CA mutation status to direct multimodality therapy?.Clin Cancer Res. 2009 Nov 15;15(22):6748-50.
19903790 - Nosho K, Kure S, Irahara N, Shima K, Baba Y, Spiegelman D, Meyerhardt JA, Giovannucci EL, Fuchs CS, Ogino S.A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers.Gastroenterology. 2009 Nov;1
19686742 - Ogino S, Nosho K, Irahara N, Meyerhardt JA, Baba Y, Shima K, Glickman JN, Ferrone CR, Mino-Kenudson M, Tanaka N, Dranoff G, Giovannucci EL, Fuchs CS.Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node co
19825961 - Kure S, Nosho K, Baba Y, Irahara N, Shima K, Ng K, Meyerhardt JA, Giovannucci EL, Fuchs CS, Ogino S.Vitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer.Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2765-72.
19789368 - Ogino S, Nosho K, Irahara N, Shima K, Baba Y, Kirkner GJ, Meyerhardt JA, Fuchs CS.Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers.J Clin Oncol. 2009 Sep 20;27(27)
19704056 - Meyerhardt JA, Ogino S, Kirkner GJ, Chan AT, Wolpin B, Ng K, Nosho K, Shima K, Giovannucci EL, Loda M, Fuchs CS.Interaction of molecular markers and physical activity on mortality in patients with colon cancer.Clin Cancer Res. 2009 Sep 15;15(18):5931-6.
19723652 - Ogino S, Nosho K, Shima K, Baba Y, Irahara N, Kirkner GJ, Hazra A, De Vivo I, Giovannucci EL, Meyerhardt JA, Fuchs CS.p21 expression in colon cancer and modifying effects of patient age and body mass index on prognosis.Cancer Epidemiol Biomarkers Prev. 20
19723919 - Souglakos J, Philips J, Wang R, Marwah S, Silver M, Tzardi M, Silver J, Ogino S, Hooshmand S, Kwak E, Freed E, Meyerhardt JA, Saridaki Z, Georgoulias V, Finkelstein D, Fuchs CS, Kulke MH, Shivdasani RA.Prognostic and predictive value of common mutations f
19603024 - Baba Y, Nosho K, Shima K, Freed E, Irahara N, Philips J, Meyerhardt JA, Hornick JL, Shivdasani RA, Fuchs CS, Ogino S.Relationship of CDX2 loss with molecular features and prognosis in colorectal cancer.Clin Cancer Res. 2009 Jul 15;15(14):4665-73.
19584150 - Ogino S, Nosho K, Irahara N, Kure S, Shima K, Baba Y, Toyoda S, Chen L, Giovannucci EL, Meyerhardt JA, Fuchs CS.A cohort study of cyclin D1 expression and prognosis in 602 colon cancer cases.Clin Cancer Res. 2009 Jul 1;15(13):4431-8.
19549773 - Zhu AX,Sahani DV,Duda DG,di Tomaso E,Ancukiewicz M,Catalano OA,Sindhwani V,Blaszkowsky LS,Yoon SS,Lahdenranta J,Bhargava P,Meyerhardt J,Clark JW,Kwak EL,Hezel AF,Miksad R,Abrams TA,Enzinger PC,Fuchs CS,Ryan DP,Jain RK.Efficacy, Safety, and Potential Bioma
19470923 - Ogino S, Shima K, Nosho K, Irahara N, Baba Y, Wolpin BM, Giovannucci EL, Meyerhardt JA, Fuchs CS.A cohort study of p27 localization in colon cancer, body mass index, and patient survival.Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1849-58.
19505918 - Kulke MH,Hornick JL,Frauenhoffer C,Hooshmand S,Ryan DP,Enzinger PC,Meyerhardt JA,Clark JW,Stuart K,Fuchs CS,Redston MS.O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors.Clin
19118063 - Fuchs CS,Goldberg RM,Sargent DJ,Meyerhardt JA,Wolpin BM,Green EM,Pitot HC,Pollak M.Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741.Clin Cancer Res. 2008 D
19073970 - Wolpin BM,Meyerhardt JA,Chan AT,Ng K,Chan JA,Wu K,Pollak MN,Giovannucci EL,Fuchs CS.Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.J Clin Oncol. 2009 Jan 10;27(2):176-85.
19064975 - Wolpin BM,Hezel AF,Abrams T,Blaszkowsky LS,Meyerhardt JA,Chan JA,Enzinger PC,Allen B,Clark JW,Ryan DP,Fuchs CS.Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer.J Clin Oncol. 2009 Jan 10;27(2):193-8.
19047305 - Ogino S,Nosho K,Meyerhardt JA,Kirkner GJ,Chan AT,Kawasaki T,Giovannucci EL,Loda M,Fuchs CS.Cohort study of fatty acid synthase expression and patient survival in colon cancer.J Clin Oncol. 2008 Dec 10;26(35):5713-20.
18955444 - Ogino S,Nosho K,Kirkner GJ,Kawasaki T,Meyerhardt JA,Loda M,Giovannucci EL,Fuchs CS.CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.Gut. 2009 Jan;58(1):90-6.
18832519 - Bracht LK,Wen P,Meyerhardt JA,Kulke MH,Hornick JL,Redston M,LaFrankie DC,Black PM,Kesari S,Norden A,Drappatz J.DNA repair enzyme expression and differential response to temozolomide in a patient with both glioblastoma and metastatic pancreatic neuroendocr
18779600 - Meyerhardt JA,Niedzwiecki D,Hollis D,Saltz LB,Mayer RJ,Nelson H,Whittom R,Hantel A,Thomas J,Fuchs CS.Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cance
18757324 - Wolpin BM,Wei EK,Ng K,Meyerhardt JA,Chan JA,Selhub J,Giovannucci EL,Fuchs CS.Prediagnostic plasma folate and the risk of death in patients with colorectal cancer.J Clin Oncol. 2008 Jul 1;26(19):3222-8.
18591557 - Ng K,Meyerhardt JA,Wu K,Feskanich D,Hollis BW,Giovannucci EL,Fuchs CS.Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer.J Clin Oncol. 2008 Jun 20;26(18):2984-91.
18565885 - Chan JA,Meyerhardt JA,Niedzwiecki D,Hollis D,Saltz LB,Mayer RJ,Thomas J,Schaefer P,Whittom R,Hantel A,Goldberg RM,Warren RS,Bertagnolli M,Fuchs CS.Association of family history with cancer recurrence and survival among patients with stage III colon cancer
18523220 - Bass AJ, Meyerhardt JA, Chan JA, Giovannucci EL, Fuchs CS.Family history and survival after colorectal cancer diagnosis.Cancer. 2008 Mar 15;112(6):1222-9.
18219663 - Meyerhardt JA, Zhu AX, Stuart K, Ryan DP, Blaszkowsky L, Lehman N, Earle CC, Kulke MH, Bhargava P, Fuchs CS.Phase-II Study of Gemcitabine and Cisplatin in Patients with Metastatic Biliary and Gallbladder Cancer.Dig Dis Sci. 2008 Feb;53(2):564-70.
17597402 - Kawasaki T, Ohnishi M, Nosho K, Suemoto Y, Kirkner GJ, Meyerhardt JA, Fuchs CS, Ogino S.CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at indivi
18204436 - Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Wu K, Fuchs CS.Aspirin dose and duration of use and risk of colorectal cancer in men.Gastroenterology. 2008 Jan;134(1):21-8.
18005960 - Kulke MH, Blaszkowsky LS, Ryan DP, Clark JW, Meyerhardt JA, Zhu AX, Enzinger PC, Kwak EL, Muzikansky A, Lawrence C, Fuchs CS.Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer.J Clin Oncol. 2007 Oct 20;25(30):4787-92.
17947726 - Ogino S, Kawasaki T, Kirkner GJ, Suemoto Y, Meyerhardt JA, Fuchs CS.Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer.Gut. 2007 Nov;56(11):1564-71.
17339237 - Ogino S, Hazra A, Tranah GJ, Kirkner GJ, Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Meyerhardt JA, Hunter DJ, Fuchs CS.MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.Carcinogenesis.
17621591 - Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, Dehari R, Meyerhardt JA, Fuchs CS, Ogino S.Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.Neoplasia. 2007 Jul
17710160 - Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Hu FB, Mayer RJ, Nelson H, Whittom R, Hantel A, Thomas J, Fuchs CS.Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.JAMA. 2007 Aug 15;298(7):754-6
17699009 - Meyerhardt JA, Clark JW, Supko JG, Eder JP, Ogino S, Stewart CF, D'Amato F, Dancey J, Enzinger PC, Zhu AX, Ryan DP, Earle CC, Mayer RJ, Michelini A, Kinsella K, Fuchs CS.Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients
17216531 - Meyerhardt J, Stuart K, Fuchs C, Zhu A, Earle C, Bhargava P, Blaszkowsky L, Enzinger P, Mayer R, Battu S, Lawrence C, Ryan D.Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastastic colorectal cancer.Ann Onco
17483115 - Zhu AX, Stuart K, Blaszkowsky LS, Muzikansky A, Reitberg DP, Clark JW, Enzinger PC, Bhargava P, Meyerhardt JA, Horgan K, Fuchs CS, Ryan DP.Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma.Cancer. 2007 Aug 1;110(3):581-9.
17583545 - Wolpin BM, Meyerhardt JA, Mamon HJ, Mayer RJ.Adjuvant treatment of colorectal cancer.CA Cancer J Clin. 2007 May-Jun;57(3):168-85. Review.
17507442 - Enzinger PC, Benedetti JK, Meyerhardt JA, McCoy S, Hundahl SA, Macdonald JS, Fuchs CS.Impact of hospital volume on recurrence and survival after surgery for gastric cancer.Ann Surg. 2007 Mar;245(3):426-34.
17435550 - Ogino S, Meyerhardt JA, Kawasaki T, Clark JW, Ryan DP, Kulke MH, Enzinger PC, Wolpin BM, Loda M, Fuchs CS.CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma.Virchows Ar
17372756 - Zhu AX, Clark JW, Ryan DP, Meyerhardt JA, Enzinger PC, Earle CC, Fuchs CS, Regan E, Anbe H, Houghton M, Zhang J, Urrea P, Kulke MH.Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastroin
16786333 - Chan JA, Meyerhardt JA, Chan AT, Giovannucci EL, Colditz GA, Fuchs CS.Hormone replacement therapy and survival after colorectal cancer diagnosis.J Clin Oncol. 2006 Dec 20;24(36):5680-6.
17179103 - Wolpin BM, Clark JW, Meyerhardt JA, Earle CC, Ryan DP, Enzinger PC, Zhu AX, Blaszkowsky L, Battu S, Fuchs CS.Phase I study of gefitinib plus FOLFIRI in previously untreated patients with metastatic colorectal cancer.Clin Colorectal Cancer. 2006 Sep;6(3):2
17026790 - Kulke MH, Bergsland EK, Ryan DP, Enzinger PC, Lynch TJ, Zhu AX, Meyerhardt JA, Heymach JV, Fogler WE, Sidor C, Michelini A, Kinsella K, Venook AP, Fuchs CS.Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.J Cl
16877721 - Meyerhardt JA, Heseltine D, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Nelson H, Whittom R, Hantel A, Schilsky RL, Fuchs CS.Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CA
16822843 - Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, Fuchs CS.Physical activity and survival after colorectal cancer diagnosis.J Clin Oncol. 2006 Aug 1;24(22):3527-34.
16822844 - Meyerhardt JA, Heseltine D, Ogino S, Clark JW, Enzinger PC, Ryan DP, Earle CC, Zhu AX, Fuchs CS.Efficacy of cetuximab after treatment with oral epidermal growth factor receptor tyrosine kinase inhibitor-based chemotherapy in metastatic colorectal cancer.C
16796793 - Meyerhardt JA, Zhu AX, Enzinger PC, Ryan DP, Clark JW, Kulke MH, Earle CC, Vincitore M, Michelini A, Sheehan S, Fuchs CS.Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancer.J Clin On
16622264 - Ogino S, Brahmandam M, Cantor M, Namgyal C, Kawasaki T, Kirkner G, Meyerhardt JA, Loda M, Fuchs CS.Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component.Mod Pathol. 2006 Jan;19
16118624 - Meyerhardt JA, Heseltine D, Campos H, Holmes MD, Willett WC, Winer EP, Enzinger PC, Bunnell CA, Kulke MH, Fuchs CS.Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapy.J Clin Oncol. 2005 Nov 20;23(33):8453-60.
16293876 - Ogino S, Meyerhardt JA, Cantor M, Brahmandam M, Clark JW, Namgyal C, Kawasaki T, Kinsella K, Michelini AL, Enzinger PC, Kulke MH, Ryan DP, Loda M, Fuchs CS.Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advance
16166444 - Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS.Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.JAMA. 2005 Aug 24;294(8):914-23.
16118381 - Meyerhardt JA, Sloan JA, Sargent DJ, Goldberg DJ, Pollak M, Morton RK, Williamson SK, Findlay BP, Fuchs CS.The associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cance
- Meyerhardt JA, Sloan JA, Sargent DJ, Goldberg RM, Pollak M, Morton RF, Ramanathan RK, Williamson SK, Findlay BP, Fuchs CS.Associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorec
15941948 - Meyerhardt JA, Mayer RJ.Systemic therapy for colorectal cancer.N Engl J Med. 2005 Feb 3;352(5):476-87.
15689586 - Meyerhardt JA, Fuchs CS.Epidermal growth factor receptor inhibitors and colorectal cancer.Oncology (Huntingt). 2004 Dec;18(14 Suppl 14):35-8.
15685832 - Meyerhardt JA, Kwok A, Ratain MJ, McGovren JP, Fuchs CS.Relationship of baseline serum bilirubin to efficacy and toxicity of single-agent irinotecan in patients with metastatic colorectal cancer.J Clin Oncol. 2004 Apr 15;22(8):1439-46.
15084617 - Meyerhardt JA, Tepper JE, Niedzwiecki D, Hollis DR, McCollum AD, Brady D, O'Connell MJ, Mayer RJ, Cummings B, Willett C, Macdonald JS, Benson AB, Fuchs CS.Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II a
14966087 - Meyerhardt JA, Tepper JE, Niedzwiecki D, Hollis DR, Schrag D, Ayanian JZ, O'Connell MJ, Weeks JC, Mayer RJ, Willett CG, MacDonald JS, Benson AB, Fuchs CS.Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk cur
14701779 - Meyerhardt JA, Catalano PJ, Schrag D, Ayanian JZ, Haller DG, Mayer RJ, Macdonald JS, Benson AB, Fuchs CS.Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence.Ann Intern Med. 2003 Oct 21;139(8):649
14568853 - Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson AB, Macdonald JS, Fuchs CS.Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma.Cancer. 2003 Aug 1;98(3):484-95.
12879464 - Meyerhardt JA, Mayer RJ.Follow-up strategies after curative resection of colorectal cancer.Semin Oncol. 2003 Jun;30(3):349-60.
12870136 - Meyerhardt JA, Fuchs CS.Adjuvant therapy in gastric cancer: can we prevent recurrences?.Oncology (Huntingt). 2003 May;17(5):714-21, 728; discussion 7.
12800796 - Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB, Fuchs CS.Impact of diabetes mellitus on outcomes in patients with colon cancer.J Clin Oncol. 2003 Feb 1;21(3):433-40.
12560431 - Meyerhardt JA, Fuchs CS.Chemotherapy options for gastric cancer.Semin Radiat Oncol. 2002 Apr;12(2):176-86.
11979419 - Reyes-Múgica M, Meyerhardt JA, Rzasa J, Rimm DL, Johnson KR, Wheelock MJ, Reale MA.Truncated DCC reduces N-cadherin/catenin expression and calcium-dependent cell adhesion in neuroblastoma cells.Lab Invest. 2001 Feb;81(2):201-10.
11232642
|
